Search

everythinglearnresearchcommunity

for

Search:↓

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

More research is needed to confirm safflower's traditional medicinal uses.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Isotretinoin effectively treats severe acne and similar conditions, but has common, mostly reversible side effects, requiring careful patient monitoring.

Older age and related diseases increase COVID-19 risk, but anti-aging treatments might help.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The guideline offers current advice for diagnosing and treating Long- and Post-COVID symptoms.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Some vaccines might rarely cause hair loss, more research is needed.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Inherited ichthyoses cause widespread skin scaling and thickening due to gene mutations.

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

Triparanol therapy can cause hair loss and skin dryness without inflammation or damage to hair follicles or skin structures.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Tattooing helps treat skin conditions, reconstruct nipple-areola, mark radiation fields, and locate lesions.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Different hair care practices and conditions affect African American hair and scalp health, requiring specialized knowledge for treatment.

KFSD is a rare condition causing scarring hair loss, with no effective treatment known at the time of the report.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Latanoprost can effectively treat eyelash hair loss, with 45% of patients showing hair regrowth and no reported side effects.